Results 111 to 120 of about 32,430 (341)

Mortality study of 18 000 patients treated with omeprazole. [PDF]

, 2002
Background: The long term safety of potent gastric acid suppressive therapy has yet to be established. Method: General practice record review at a median interval of 26 months followed by retrieval of details of all deaths within four years using the ...
Bateman, D.N., Colin-Jones, D., Hartz, S., Langman, M., Logan, R.F., Mant, J.W.F., Murphy, M, Paterson, K.R., Rowsell, R., Thomes, S.   +9 more
core  

Pancreatic Suppurative Process: A Rare Case of Pancreato-duodenal Fistula with an Intraductal Papillary Mucinous Neoplasm [PDF]

, 2023
Javier González‐Gallego, Javier Chapochnick, Carlos Derosas, I. Nachari   +3 more
openalex   +1 more source

A subcentimeter duodenal neuroendocrine neoplasm with a liver metastasis upgraded to G3: a case report [PDF]

, 2021
Tomoya Kitada, Toshihiko Masui, Yosuke Kasai, Yuichiro Uchida, Satoshi Ogiso, Takashi Ito, Takamichi Ishii, Satoru Seo, Hiroyuki Katsuragawa, Shinji Üemoto   +9 more
openalex   +1 more source

Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis

Ibrain, Volume 11, Issue 1, Page 74-83, Spring 2025.
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley   +1 more source

Endoscopic treatment for duodenal neoplasms [PDF]

Digestive Endoscopy, 2021
openaire   +2 more sources

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol

International Journal of Cancer, EarlyView.
What's New? PARP inhibitors are effective in patients with inactivating alterations in the BRCA1/2 genes across tumor types. However, the efficacy of PARP inhibitors in patients with other inactivated homologous recombination repair genes remains unclear. This knowledge gap and discrepancies in EMA/FDA approvals highlight the need for better biomarkers.
Ilse A. C. Spiekman, Niven Mehra, Laurien J. Zeverijn, Birgit S. Geurts, Karlijn Verkerk, Soemeya F. Haj Mohammad, Vincent van der Noort, Paul Roepman, Wendy W. J. de Leng, Anne M. L. Jansen, Addy C. M. van de Luijtgaarden, Theo van Voorthuizen, Tineke E. Buffart, Hans Gelderblom, Emile E. Voest, Henk M. W. Verheul   +15 more
wiley   +1 more source

Efficacy and safety of endoscopic submucosal dissection versus endoscopic papillectomy for managing laterally spreading duodenal papillary tumors [PDF]

Clinical Endoscopy
Background/Aim Endoscopic submucosal dissection (ESD) can be performed to treat laterally spreading duodenal papillary tumors (LSPTs). However, no studies have been conducted on the outcomes of ESD for LSPTs.
Yuki Kano, Ken Ohata, Toshifumi Iida, Susumu Banjoya, Tomoya Kimura, Koichi Furuta, Shinya Nagae, Yohei Ito, Hiroshi Yamazaki, Nao Takeuchi, Shunya Takayanagi, Yoshiaki Kimoto, Yuji Koyama, Seitaro Tsujino, Takashi Sakuno, Kohei Ono, Yohei Minato, Yuji Fujita, Eiji Sakai, Hideyuki Chiba   +19 more
doaj   +1 more source

Organ‐sparing strategies in patients with MSI/dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making

International Journal of Cancer, EarlyView.
Abstract Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in ...
Martin Duval, Antoine Dardenne, Thomas Samaille, Leo Mas, Jérémie H. Lefèvre, Xavier Dray, Mathilde Wagner, Romain Cohen, Thierry André   +8 more
wiley   +1 more source

Inflammatory myofibroblastic tumors of the duodenum

Asian Journal of Surgery, 2016
Inflammatory myofibroblastic tumors (IMTs) are rare soft-tissue tumors that can occur at virtually any anatomical site. We report the case of a 58-year-old male with an IMT of the fourth part of the duodenum who presented with signs and symptoms of high ...
Igor Petrovic, Goran Augustin, Ljiljana Hlupic, Ana Nedic, Ivan Romic, Mate Skegro   +5 more
doaj   +1 more source

Serotonin- and Somatostatin-Positive Goblet Cell Carcinoid of the Duodenum [PDF]

, 2012
In the duodenum, mixed exocrine-endocrine tumors exhibiting both neuroendocrine and glandular differentiations [cf. appendiceal goblet cell carcinoids (GCCs)] are rare.
Hase, Kazuo, Kaga, Hitoshi, Matsuzaki, Koji, Niihara, Naoko, Ogata, Sho, Ogawa, Tomomichi, Ohara, Ichiyou, Okusa, Yasushi, Tominaga, Susumu   +8 more
core   +1 more source